105 related articles for article (PubMed ID: 19708990)
1. Highlights and hotspots of protein glycation in end-stage renal disease.
Thornalley PJ; Rabbani N
Semin Dial; 2009; 22(4):400-4. PubMed ID: 19708990
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products in renal failure.
Thornalley PJ
J Ren Nutr; 2006 Jul; 16(3):178-84. PubMed ID: 16825015
[TBL] [Abstract][Full Text] [Related]
3. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
4. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed N; Thornalley PJ
Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
[TBL] [Abstract][Full Text] [Related]
7. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
Kanková K
Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
[TBL] [Abstract][Full Text] [Related]
8. Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?
Sebeková K; Wagner Z; Schupp N; Boor P
Kidney Blood Press Res; 2007; 30(1):56-66. PubMed ID: 17261927
[TBL] [Abstract][Full Text] [Related]
9. Increased protein glycation in cirrhosis and therapeutic strategies to prevent it.
Ahmed N; Lüthen R; Häussinger D; Sebeková K; Schinzel R; Voelker W; Heidland A; Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():718-24. PubMed ID: 16037298
[TBL] [Abstract][Full Text] [Related]
10. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
11. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A
J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123
[TBL] [Abstract][Full Text] [Related]
12. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
14. Protein glycation in vivo: functional and structural effects on yeast enolase.
Gomes RA; Oliveira LM; Silva M; Ascenso C; Quintas A; Costa G; Coelho AV; Sousa Silva M; Ferreira AE; Ponces Freire A; Cordeiro C
Biochem J; 2008 Dec; 416(3):317-26. PubMed ID: 18651835
[TBL] [Abstract][Full Text] [Related]
15. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis.
Schmitt S; Linder M; Ständker L; Hammes HP; Preissner KT
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):26-34. PubMed ID: 17926233
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers.
Yamagishi S; Matsui T; Nakamura K
Med Hypotheses; 2008 Aug; 71(2):259-61. PubMed ID: 18448262
[TBL] [Abstract][Full Text] [Related]
17. Increased glycation of hemoglobin in chronic renal failure: [corrected] potential role of oxidative stress.
Selvaraj N; Bobby Z; Sridhar MG
Arch Med Res; 2008 Apr; 39(3):277-84. PubMed ID: 18279699
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
Kalousová M; Zima T; Tesar V; Dusilová-Sulková S; Skrha J
Mutat Res; 2005 Nov; 579(1-2):37-46. PubMed ID: 16084533
[TBL] [Abstract][Full Text] [Related]
19. Measurement of protein glycation, glycated peptides, and glycation free adducts.
Thornalley PJ
Perit Dial Int; 2005; 25(6):522-33. PubMed ID: 16419322
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors.
Schupp N; Schinzel R; Heidland A; Stopper H
Ann N Y Acad Sci; 2005 Jun; 1043():685-95. PubMed ID: 16037294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
